Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Uroxatral (alfuzosin hydrochloride) extended release tablets
Company:  Sanofi-Synthelabo Inc.
Application No.:  021287
Approval Date: 6/12/2003


Date created: September 9, 2003

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.